Lung Cancer: Split-Course Palliative Radiotherapy Confirmed as Effective Treatment for Advanced NSCLC
ScienceDaily (Feb. 16, 2010) — Research published in the February edition of the Journal of Thoracic Oncology sought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen's two-week break has on survival outcomes.
...
Patients with chronic myeloid leukemia frequently relapse after discontinuation of imatinib, but results of a recently published study indicate that treatment with interferon-alfa alone allowed patients with the disease to discontinue treatment with the tyrosine kinase inhibitor and maintain treatment response.
“The results presented here challenge the current view of permanent imatinib treatment as the unequivocal standard...
Intravesical bacillus Calmette-Guérin (BCG) with and without isoniazid (INH) is associated with outcomes superior to those intravesical epirubicin in patients with intermediate- and high-risk Ta and T1 urothelial bladder cancer.
In a study of 837 patients, instillation of BCG alone or with INH decreased the risk of disease recurrence, distant metastases, overall survival, and disease-specific...
ScienceDaily (Feb. 17, 2010) — Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight.
The good news is that there may soon be a new weapon in the battle against the so-called "worst" cancer -- cancer of the pancreas. A multidisciplinary group of investigators from the UCLA School of Dentistry, the David Geffen School of Medicine at UCLA, the UCLA School of Public Health...
New Recommendations for Colorectal Cancer Surveillance for Certain Patients With Inflammatory Bowel Disease
ScienceDaily (Feb. 16, 2010) — Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients,...
